Hinge Health, Inc. (HNGE) Stock Price & Analysis
Hinge Health, Inc. (HNGE) closed at USD 109.93 on Thursday, October 22, 2026, down 1.85% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 112; the Oct 22, 2026 session ranged USD 108.5–113.48 on volume of 2,263,951 shares. Market capitalization is $8.87B, with a 52-week range of USD 30.08–113.48 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:26 UTC.
Also available as compact Markdown for AI agents: nexqual.com/HNGE.md
Key facts (HNGE)
- Last four reported quarters (through Jun 30, 2026): revenue $720M, net income $109M (15.1% margin), free cash flow $290M (SEC filings).
- Valuation: P/E 81.3x.
- 1 of 80 tracked superinvestors hold HNGE (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 1.65 on a 1–5 scale) (17 analysts), mean target USD 112.13 (range 90–140).
- Total return with dividends: 1Y +121.9% vs S&P 500 +14.9%; 5Y +173.7% vs S&P 500 +80.3%.
- Next earnings: 2026-11-02, EPS estimate USD 0.6, revenue estimate $225M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (HNGE)
| USD | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|
| Revenue | $293M | $390M | $588M | $720M |
| Gross profit | $194M | $300M | $468M | — |
| Operating income | -$131M | -$31.9M | -$546M | $93.7M |
| Net income | -$108M | -$11.9M | -$528M | $109M |
| EPS (diluted) | -$8.31 | -$0.88 | -$7.77 | — |
| Free cash flow | -$65.9M | $48.0M | $171M | $290M |
| Gross margin | 66.3% | 76.8% | 79.6% | — |
| Operating margin | -44.6% | -8.2% | -92.9% | 13.0% |
| Net margin | -36.9% | -3.1% | -89.9% | 15.1% |
| Revenue growth | — | +33.4% | +50.6% | — |
| Cash + short-term investments | $235M | $467M | $364M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (HNGE)
P/E 81.3x · P/S 12.3x · P/FCF 30.6x · P/B 25.8x · FCF yield 3.27% · Earnings yield 1.23%
Superinvestors (SEC 13F-HR, Q2 2026) (HNGE)
1 of 80 tracked investors hold HNGE. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.06% | $35.7M | Added +27.7% |
Analysts (HNGE)
Consensus Buy (mean 1.65 on a 1–5 scale), 17 analysts; mean target USD 112.13 (low 90, high 140).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-16 | Keybanc | Target raised | Overweight | $125 → $140 |
| 2026-10-12 | Barclays | Target raised | Overweight | $100 → $110 |
| 2026-09-30 | Needham | Target raised | Buy | $97 → $115 |
| 2026-09-22 | Baird | Target raised | Neutral | $85 → $90 |
| 2026-09-08 | Stifel | Target raised | Buy | $96 → $115 |
| 2026-08-11 | Truist Securities | Target raised | Buy | $85 → $112 |
| 2026-08-05 | RBC Capital | Target raised | Outperform | $75 → $110 |
| 2026-08-05 | Citizens | Target raised | Market Outperform | $96 → $107 |
| 2026-08-05 | Wells Fargo | Target raised | Overweight | $90 → $103 |
| 2026-08-05 | Evercore ISI Group | Target raised | Outperform | $100 → $105 |
| 2026-08-05 | Barclays | Target raised | Overweight | $97 → $100 |
| 2026-08-05 | Needham | Target raised | Buy | $76 → $97 |
Total return (dividends reinvested) (HNGE)
| 1Y (from 2025-10-23) | 5Y (from 2025-05-19) | |
|---|---|---|
| Total return | +121.9% | +173.7% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +122.5% | +102.4% |
| Volatility (annualized) | 53.4% | 62.7% |
| Max drawdown | -41.7% (Nov 2025→Feb 2026) | -47.2% (Aug 2025→Feb 2026) |
HNGE analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.60 | $0.68 | -12.6% | $224.8M | 13 |
| Next quarter (ends Dec 2026) | $0.66 | $0.80 | -17.7% | $239.6M | 13 |
| Current fiscal year (ends Dec 2026) | $2.40 | $2.60 | -7.7% | $860.6M | 14 |
| Next fiscal year (ends Dec 2027) | $3.06 | $3.40 | -10.1% | $1.09B | 13 |
Key Statistics (as of October 23, 2026 at 09:26 UTC)
| Price | USD 109.93 |
|---|---|
| Change | ▼ 1.85% (down) |
| Previous Close | USD 112 |
| Open | USD 112.59 |
| Day Range | USD 108.5 – 113.48 |
| 52-Week Range | USD 30.08 – 113.48 |
| Volume | 2,263,951 shares |
| Market Cap | $8.87B |
| Exchange | NYQ |
Technical Analysis (HNGE)
Nexqual's technical model rates HNGE "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 23, 2026 at 09:26 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 66.59 (neutral) |
| vs SMA50 | Above (USD 95.02) |
| MACD | 4.14 (positive) |
Analyst Ratings (HNGE)
Wall Street analysts rate HNGE "Buy" based on 17 analysts, with a mean price target of USD 112.13 (range USD 90–140), per Nexqual as of October 23, 2026 at 09:26 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 17 |
| Mean Target | USD 112.13 |
| High Target | USD 140 |
| Low Target | USD 90 |
| Buy / Hold / Sell | 16 / 1 / 0 |
Earnings (HNGE)
| Next Earnings Date | 2026-11-02 |
|---|---|
| EPS Estimate | USD 0.6 |
| Revenue Estimate | $224.78M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.59 vs est 0.62 ▼ miss |
| 2026-03-31 | USD 0.45 vs est 0.4 ▲ beat |
| 2025-12-31 | USD 0.49 vs est 0.43 ▲ beat |
| 2025-09-30 | USD 0.44 vs est 0.24 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financials & Fundamentals (HNGE)
| Total Revenue | $720.06M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +53.00% |
| Gross Margin | +84.54% |
| Operating Margin | +19.00% |
| Profit Margin | +15.15% |
| ROE | +30.38% |
| Debt / Equity | 0.02 |
| Current Ratio | 1.34 |
| Total Cash | $389.39M |
| Total Debt | $5.88M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $290.12M (40.3% of revenue) |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financial Health Score (HNGE)
Nexqual rates Hinge Health, Inc.'s overall financial health "Strong" across five dimensions, as of October 23, 2026 at 09:26 UTC.
| Growth | Strong — Revenue +53% YoY (latest Q) |
|---|---|
| Profitability | Strong — Gross margin 85%, operating 19% (last 12 months) |
| Balance Sheet | Strong — $389M cash vs $6M debt, net cash position |
| Cash Flow | Strong — FCF $290M (last 4 quarters to Jun 2026, SEC), 40% margin |
| Efficiency | Strong — ROE 30%, ROA 7.7% |
Ownership (HNGE)
| Insider Ownership | +4.75% |
|---|---|
| Institutional Ownership | +98.76% |
| Shares Outstanding | 62.47M |
| Float | 50.62M |
| Short % of Float | +10.27% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Leadership (HNGE)
Hinge Health, Inc. is led by Daniel A. Perez, Co-Founder, CEO & Director, per Nexqual as of October 23, 2026 at 09:26 UTC.
| Co-Founder, CEO & Director | Daniel A. Perez |
|---|---|
| Co-Founder, CTO & Executive Chairman | Gabriel Mecklenburg |
| President | James Pursley |
| Chief Financial Officer | James W. Budge |
| Chief Operating Officer | Alexander Annison |
Major Backers & Investors (HNGE)
Notable institutional backers of Hinge Health, Inc. include 11.2 Capital Management, LLC, Deer Management Co. LLC, Assenagon Asset Management S.A., according to Nexqual as of October 23, 2026 at 09:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| 11.2 Capital Management, LLC | 3.95% |
| Deer Management Co. LLC | 3.06% |
| Assenagon Asset Management S.A. | 2.97% |
| Two Sigma Investments, LP | 2.89% |
| Fuller & Thaler Asset Management Inc. | 2.74% |
| Morgan Stanley | 2.58% |
| Franklin Resources, Inc. | 2.53% |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Growth Fund | 1.76% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 6.47% |
| BlackRock | 5.72% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HQY | HealthEquity, Inc. | USD 100.97 | ▲ 3.16% |
| TEM | Tempus AI, Inc. | USD 63.81 | ▼ 5.83% |
| BTSG | BrightSpring Health Services, I | USD 60.86 | ▼ 2.41% |
| DOCS | Doximity, Inc. | USD 33.68 | ▲ 0.3% |
| WAY | Waystar Holding Corp. | USD 28.98 | ▲ 0.49% |
| HTFL | Heartflow, Inc. | USD 55.43 | ▼ 0.7% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:26 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt